投稿信息
投稿信息
員@2x.png)
審稿費(fèi)用
暫無數(shù)據(jù)
版面費(fèi)用
暫無數(shù)據(jù)
中國(guó)人發(fā)表比例
2023年中國(guó)人文章占該期刊總數(shù)量65.48% (2022年為66.24%)
自引率
3.3 %
年文章數(shù)
4498
期刊官網(wǎng)
點(diǎn)擊查看
(點(diǎn)擊次數(shù):62881)
投稿鏈接
點(diǎn)擊查看
(點(diǎn)擊次數(shù):38836次)
作者需知
點(diǎn)擊查看
(點(diǎn)擊次數(shù):5070次)
NCBI查詢
偏重的研究方向
期刊簡(jiǎn)介
稿件收錄要求
稿件收錄要求
Cancer Letters is a journal providing rapid publication of brief articles in the broad area of cancer research. The journal places emphasis on the molecular and cell biology of cancer, oncogenes, carcinogenesis, radiation biology, molecular pathology, hormones and cancer, viral oncology, biology of cancer and metastasis, molecular cytogenetics, epidemiology; and experimental therapeutics. The primary criterion for publication is interest to a multidisciplinary audience. Papers should be brief but technically sound and substantiated by sufficient experimental detail. Clinical papers will be accepted if they contribute to the understanding of the basic mechanisms underlying disease. Papers published in Cancer Letters from January 2001 onwards will be divided into the following sections: Carcinogenesis & Cancer Prevention, Experimental Therapeutics, Epidemiology & Molecular Epidemiology, Molecular & Cell Biology, Tumour Biology. Authors are kindly requested to select the section where they wish their manuscript to appear when submitting their manuscript to the appropriate Editorial Office (please refer to the Guide for Authors for more information).
常用鏈接
期刊論壇
|
中國(guó)SCI論文
|
期刊介紹
|
投稿信息
|
雜志官網(wǎng)
|
投稿鏈接
|
作者需知
|
PMC鏈接
|
Pubmed全文檢索
